2021 Update on Systemic Therapy for Breast Cancer
Over the past years, new systemic therapies for advanced and metastatic breast cancer have emerged, resulting in significantly improved survival outcomes in this patient population. This article provides a summary of selected clinically relevant studies presented at the 2021 European Society for Med...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2022-03-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/HBT.OH.2022.11.070 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846126485988966400 |
|---|---|
| author | Anton Oseledchyk Christian Kurzeder Angela Kohler Marcus Vetter |
| author_facet | Anton Oseledchyk Christian Kurzeder Angela Kohler Marcus Vetter |
| author_sort | Anton Oseledchyk |
| collection | DOAJ |
| description | Over the past years, new systemic therapies for advanced and metastatic breast cancer have emerged, resulting in significantly improved survival outcomes in this patient population. This article provides a summary of selected clinically relevant studies presented at the 2021 European Society for Medical Oncology (ESMO) Congress, American Society of Clinical Oncology (ASCO) Annual Meeting and San Antonio Breast Cancer Symposium (SABCS), including updated results from pivotal trials and new data on emerging therapies. |
| format | Article |
| id | doaj-art-3013aab9b0f1415cbe0a3ec868aafba1 |
| institution | Kabale University |
| issn | 2673-2106 |
| language | English |
| publishDate | 2022-03-01 |
| publisher | THE HEALTHBOOK COMPANY LTD. |
| record_format | Article |
| series | healthbook TIMES. Oncology Hematology |
| spelling | doaj-art-3013aab9b0f1415cbe0a3ec868aafba12024-12-12T17:11:14ZengTHE HEALTHBOOK COMPANY LTD.healthbook TIMES. Oncology Hematology2673-21062022-03-011112021 Update on Systemic Therapy for Breast CancerAnton OseledchykChristian KurzederAngela KohlerMarcus VetterOver the past years, new systemic therapies for advanced and metastatic breast cancer have emerged, resulting in significantly improved survival outcomes in this patient population. This article provides a summary of selected clinically relevant studies presented at the 2021 European Society for Medical Oncology (ESMO) Congress, American Society of Clinical Oncology (ASCO) Annual Meeting and San Antonio Breast Cancer Symposium (SABCS), including updated results from pivotal trials and new data on emerging therapies.https://doi.org/10.36000/HBT.OH.2022.11.070 |
| spellingShingle | Anton Oseledchyk Christian Kurzeder Angela Kohler Marcus Vetter 2021 Update on Systemic Therapy for Breast Cancer healthbook TIMES. Oncology Hematology |
| title | 2021 Update on Systemic Therapy for Breast Cancer |
| title_full | 2021 Update on Systemic Therapy for Breast Cancer |
| title_fullStr | 2021 Update on Systemic Therapy for Breast Cancer |
| title_full_unstemmed | 2021 Update on Systemic Therapy for Breast Cancer |
| title_short | 2021 Update on Systemic Therapy for Breast Cancer |
| title_sort | 2021 update on systemic therapy for breast cancer |
| url | https://doi.org/10.36000/HBT.OH.2022.11.070 |
| work_keys_str_mv | AT antonoseledchyk 2021updateonsystemictherapyforbreastcancer AT christiankurzeder 2021updateonsystemictherapyforbreastcancer AT angelakohler 2021updateonsystemictherapyforbreastcancer AT marcusvetter 2021updateonsystemictherapyforbreastcancer |